An international team, headed by researchers at the University of California, San Diego School of Medicine, has identified a key enzyme in the reprogramming process that promotes malignant stem cell cloning and the growth of chronic myeloid leukemia , a cancer of the blood and marrow that experts say is increasing in prevalence.
http://www.news-medical.net/post.aspx?id=8172ddbb-3f03-4d1a-8254-0ab343b37a7c
http://www.news-medical.net/post.aspx?id=8172ddbb-3f03-4d1a-8254-0ab343b37a7c
No comments:
Post a Comment